Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study

Authors

  • José Gomes Batista Federal University of Paraíba; Obstetrics and Gynecology Department
  • José Maria Soares-Jr Universidade de São Paulo; Faculdade de Medicina; Hospital das Clínicas
  • Carla Cristina Maganhin Federal University of São Paulo; Gynecology Department
  • Ricardo Santos Simões Universidade de São Paulo; Faculdade de Medicina; Hospital das Clínicas
  • Geraldez Tomaz Federal University of Paraíba; Obstetrics and Gynecology Department
  • Edmund Chada Baracat Universidade de São Paulo; Faculdade de Medicina; Hospital das Clínicas

DOI:

https://doi.org/10.6061/clinics/2012(03)14

Downloads

Download data is not yet available.

Downloads

Published

2012-01-01

Issue

Vol. 67 No. 3 (2012)

Section

Rapid Communications

How to Cite

Batista, J. G., Soares-Jr, J. M., Maganhin, C. C., Simões, R. S., Tomaz, G., & Baracat, E. C. (2012). Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study. Clinics, 67(3), 283-287. https://doi.org/10.6061/clinics/2012(03)14